Presenilins, the endoplasmic reticulum, and neuronal apoptosis in Alzheimer's disease

被引:0
作者
Mattson, MP
Guo, Q
Furukawa, K
Pedersen, WA
机构
[1] Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY 40536 USA
[2] Univ Kentucky, Dept Anat & Neurobiol, Lexington, KY 40536 USA
关键词
amyloid beta-peptide; amyloid precursor protein; apoptosis; calcium homeostasis; inositol trisphosphate; muscarinic cholinergic; nerve growth factor; reactive oxygen species; vitamin E;
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Many cases of autosomal dominant inherited forms of early-onset Alzheimer's disease are caused by mutations in the genes encoding presenilin-1 (PS-1; chromosome 14) and presenilin-2 (PS-2; chromosome 1). PSs are expressed in neurons throughout the brain wherein they appear to be localized primarily to the endoplasmic reticulum (ER) of cell bodies and dendrites. PS-1 and PS-2 show high homology and are predicted to have eight transmembrane domains with the C terminus, N terminus, and a loop domain all on the cytosolic side of the membrane; an enzymatic cleavage of PSs occurs at a site near the loop domain. The normal function of PSs is unknown, but data suggest roles in membrane trafficking, amyloid precursor protein processing, and regulation of ER calcium homeostasis. Homology of PSs to the C. elegans gene sel-12, which is involved in Notch signaling, and phenotypic similarities of PS-1 and Notch knockout mice suggest a developmental role for PSs in the nervous system. When expressed in cultured cells and transgenic mice, mutant PSs promote increased production of a long form of amyloid beta-peptide (A beta 1-42) that may possess enhanced amyloidogenic and neurotoxic properties, PS mutations sensitize cultured neural cells to apoptosis induced by trophic factor withdrawal, metabolic insults, and amyloid beta-peptide. The mechanism responsible for the proapoptotic action of mutant PSs may involve perturbed calcium release from ER stores and increased levels of oxidative stress. Recent studies of apoptosis in many different cell types suggest that ER calcium signaling can modulate apoptosis. The evolving picture of PS roles in neuronal plasticity and Alzheimer's disease is bringing to the forefront the ER, an organelle increasingly recognized as a key regulator of neuronal plasticity and survival.
引用
收藏
页码:1 / 14
页数:14
相关论文
共 111 条
[1]  
Barger SW, 1996, MOL BRAIN RES, V40, P116
[2]   THE CHOLINERGIC HYPOTHESIS OF GERIATRIC MEMORY DYSFUNCTION [J].
BARTUS, RT ;
DEAN, RL ;
BEER, B ;
LIPPA, AS .
SCIENCE, 1982, 217 (4558) :408-417
[3]   ARE REACTIVE OXYGEN SPECIES INVOLVED IN ALZHEIMERS-DISEASE [J].
BENZI, G ;
MORETTI, A .
NEUROBIOLOGY OF AGING, 1995, 16 (04) :661-674
[4]   Developmental regulation of presenilin mRNA expression parallels notch expression [J].
Berezovska, O ;
Xia, MQ ;
Page, K ;
Wasco, W ;
Tanzi, RE ;
Hyman, BT .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1997, 56 (01) :40-44
[5]   Familial Alzheimer's disease-linked presenilin 1 variants elevate A beta 1-42/1-40 ratio in vitro and in vivo [J].
Borchelt, DR ;
Thinakaran, G ;
Eckman, CB ;
Lee, MK ;
Davenport, F ;
Ratovitsky, T ;
Prada, CM ;
Kim, G ;
Seekins, S ;
Yager, D ;
Slunt, HH ;
Wang, R ;
Seeger, M ;
Levey, AI ;
Gandy, SE ;
Copeland, NG ;
Jenkins, NA ;
Price, DL ;
Younkin, SG .
NEURON, 1996, 17 (05) :1005-1013
[6]   Mutation analysis of presenilin 1 gene in Alzheimer's disease [J].
Boteva, K ;
Vitek, M ;
Mitsuda, H ;
deSilva, H ;
Xu, PT ;
Small, G ;
Gilbert, JR .
LANCET, 1996, 347 (8994) :130-131
[7]  
Bouras C, 1996, LANCET, V347, P1185
[8]   BIOENERGETIC AND OXIDATIVE STRESS IN NEURODEGENERATIVE DISEASES [J].
BOWLING, AC ;
BEAL, MF .
LIFE SCIENCES, 1995, 56 (14) :1151-1171
[9]   Neuronal localization of presenilin-1 and association with amyloid plaques and neurofibrillary tangles in Alzheimer's disease [J].
Busciglio, J ;
Hartmann, H ;
Lorenzo, A ;
Wong, C ;
Baumann, K ;
Sommer, B ;
Staufenbiel, M ;
Yankner, BA .
JOURNAL OF NEUROSCIENCE, 1997, 17 (13) :5101-5107
[10]   A novel presenilin 1 mutation resulting in familial Alzheimer's disease with an onset age of 29 years [J].
Campion, D ;
Brice, A ;
Dumanchin, C ;
Puel, M ;
Baulac, M ;
delaSayette, V ;
Hannequin, D ;
Duyckaerts, C ;
Michon, A ;
Martin, C ;
Moreau, V ;
Penet, C ;
Martinez, M ;
ClergetDarpoux, F ;
Agid, Y ;
Frebourg, T .
NEUROREPORT, 1996, 7 (10) :1582-1584